ascorbic-acid and Venous-Thrombosis

ascorbic-acid has been researched along with Venous-Thrombosis* in 5 studies

Reviews

1 review(s) available for ascorbic-acid and Venous-Thrombosis

Article	Year
[An orange a day keeps the scurvy away]. La Radiologia medica, 1999, Volume: 98, Issue:6 Topics: Ascorbic Acid; Citrus; Diagnosis, Differential; Female; Humans; Infant; Leg; Magnetic Resonance Imaging; Radiography; Scurvy; Venous Thrombosis	1999

Trials

1 trial(s) available for ascorbic-acid and Venous-Thrombosis

Article	Year
Use of microcirculatory parameters to evaluate clinical treatments of chronic venous disorder (CVD). Microvascular research, 2008, Volume: 76, Issue:1 To evaluate changes on cutaneous microangiopathy in chronic venous disorder (CVD) after use of Cirkan [venotonic drug containing Ruscus aculeatus (plant extract), hesperidine methylchalcone (flavonoid) and vitamin C], elastic compression stockings (ECS) or no treatment for four weeks.. Fifty-five female patients (85 legs), 25 to 57 years, with at least one limb classified as C2,s or C2,3,s (CEAP classification), were allocated consecutively, according to entrance order, in these three groups. Ten healthy women age-matched were also investigated. Using orthogonal polarization spectral technique (noninvasive method), measurements of functional capillary density (FCD, number of capillaries with flowing red blood cells/mm(2)), capillary morphology (CM, % of abnormal capillaries/mm(2)) and diameters (mum) of dermal papilla (DDP), capillary bulk (DCB) and capillary limb (CD) were obtained on the medial perimalleolar region and later analyzed using CapImage software.. CVD patients showed significant changes on CD and CM compared to healthy subjects in agreement with our previous findings (J Vasc Surg 43:1037-1044, 2006). On Cirkan-treated patients, after 4 weeks, CD decreased on both limbs and CM improved on the left one, suggesting an amelioration of the chronic venous hypertension. No significant changes could be detected on other patient groups. These results confirm the existence of microcirculatory dysfunction in early stages of CVD, probably due to post-capillary hypertension, and further support the venotonic action of Cirkan. Topics: Adult; Ascorbic Acid; Capillaries; Chymotrypsin; Combined Modality Therapy; Drug Combinations; Edema; Female; Hesperidin; Humans; Leg; Microcirculation; Middle Aged; Phytosterols; Plant Extracts; Stockings, Compression; Treatment Outcome; Trypsin; Venous Insufficiency; Venous Thrombosis	2008

Article

Year

Use of microcirculatory parameters to evaluate clinical treatments of chronic venous disorder (CVD).

Microvascular research, 2008, Volume: 76, Issue:1

To evaluate changes on cutaneous microangiopathy in chronic venous disorder (CVD) after use of Cirkan [venotonic drug containing Ruscus aculeatus (plant extract), hesperidine methylchalcone (flavonoid) and vitamin C], elastic compression stockings (ECS) or no treatment for four weeks.. Fifty-five female patients (85 legs), 25 to 57 years, with at least one limb classified as C2,s or C2,3,s (CEAP classification), were allocated consecutively, according to entrance order, in these three groups. Ten healthy women age-matched were also investigated. Using orthogonal polarization spectral technique (noninvasive method), measurements of functional capillary density (FCD, number of capillaries with flowing red blood cells/mm(2)), capillary morphology (CM, % of abnormal capillaries/mm(2)) and diameters (mum) of dermal papilla (DDP), capillary bulk (DCB) and capillary limb (CD) were obtained on the medial perimalleolar region and later analyzed using CapImage software.. CVD patients showed significant changes on CD and CM compared to healthy subjects in agreement with our previous findings (J Vasc Surg 43:1037-1044, 2006). On Cirkan-treated patients, after 4 weeks, CD decreased on both limbs and CM improved on the left one, suggesting an amelioration of the chronic venous hypertension. No significant changes could be detected on other patient groups. These results confirm the existence of microcirculatory dysfunction in early stages of CVD, probably due to post-capillary hypertension, and further support the venotonic action of Cirkan.

Topics: Adult; Ascorbic Acid; Capillaries; Chymotrypsin; Combined Modality Therapy; Drug Combinations; Edema; Female; Hesperidin; Humans; Leg; Microcirculation; Middle Aged; Phytosterols; Plant Extracts; Stockings, Compression; Treatment Outcome; Trypsin; Venous Insufficiency; Venous Thrombosis

2008

Other Studies

3 other study(ies) available for ascorbic-acid and Venous-Thrombosis

Article	Year
[Systemic poly-enzyme therapy in prophylaxis of venous blood circulation disorder in the lower limbs in modern sport]. Voenno-meditsinskii zhurnal, 2008, Volume: 329, Issue:5 Topics: Adult; Ascorbic Acid; Aspirin; Drug Combinations; Drug Therapy, Combination; Humans; Hydrolases; Leg; Male; Microcirculation; Regional Blood Flow; Rutin; Sports; Treatment Outcome; Venous Thrombosis	2008
[Clinical observations in the use of ethyl bis-coumacetate in venous thrombosis in obstetrics and gynecology]. Il Policlinico. Sezione pratica, 1954, May-24, Volume: 61, Issue:21 Topics: Ascorbic Acid; Coumarins; Female; Flavonoids; Genitalia; Genitalia, Female; Gynecology; Humans; Obstetrics; Postpartum Period; Thrombosis; Venous Thrombosis; Vitamin E; Vitamins	1954
[Study of anticoagulants in therapy of venous thrombosis in obstetrics and gynecology]. Minerva ginecologica, 1954, Apr-30, Volume: 6, Issue:8 Topics: Anticoagulants; Ascorbic Acid; Female; Genital Diseases, Female; Gynecology; Humans; Obstetrics; Pregnancy; Thrombophlebitis; Thrombosis; Venous Thrombosis; Vitamin E	1954